Home Biosimilar Antibodies Immunology & Inflammation IFN antibody Rontalizumab (Anti-IFNa1) For research use only.
Not for use in humans.

Rontalizumab (Anti-IFNa1)

Synonyms: RhuMab IFNalpha

Rontalizumab (Anti-IFNa1) is a humanized IgG1 monoclonal antibody targets IFN-α. It can be used for the research of systemic lupus erythematosus. MW :150 KD.

Rontalizumab (Anti-IFNa1)

Purity & Quality Control

≥99

Choose Selective IFN Inhibitors

Biological Activity

Description Rontalizumab (Anti-IFNa1) is a humanized IgG1 monoclonal antibody targets IFN-α. It can be used for the research of systemic lupus erythematosus. MW :150 KD.

Product Details

CAS No. 948570-30-7
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rontalizumab (Anti-IFNa1) | Rontalizumab (Anti-IFNa1) supplier | purchase Rontalizumab (Anti-IFNa1) | Rontalizumab (Anti-IFNa1) cost | Rontalizumab (Anti-IFNa1) manufacturer | order Rontalizumab (Anti-IFNa1) | Rontalizumab (Anti-IFNa1) distributor